文献速递脑血管病

血管内取栓辅助动脉内溶栓的系统综述与荟萃分析

Adjunctive Intra-arterial Thrombolysis in Endovascular Thrombectomy: A Systematic Review and Meta-analysis.
PubMed 文献 · Neurology · 2021-06-14

本研究系统检索文献并纳入5项比较血管内取栓(EVT)与EVT联合辅助动脉内溶栓(IAT)的研究,共1693例患者。荟萃分析未发现两组在症状性颅内出血、3个月死亡率或成功再灌注方面存在差异,EVT+IAT组功能独立率较高但未达统计学显著性。结论认为辅助IAT似乎安全,神经介入医师可在特定情况下作为补救治疗使用小剂量动脉内阿替普酶或尿激酶。

要点

  • 辅助动脉内溶栓未增加症状性颅内出血或死亡风险。
  • 联合治疗组功能独立率有升高趋势但无统计学意义。
  • 特定情况下可考虑小剂量动脉内阿替普酶或尿激酶作为补救治疗。

核心结论

  • 辅助动脉内溶栓似乎安全,特定情况下可作为血管内取栓的补救治疗。

研究设计与样本

  • 系统综述与随机效应荟萃分析,检索MEDLINE、Embase和Cochrane数据库。
  • 纳入5项比较EVT联合辅助IAT与单纯EVT的研究,共1693例患者,其中269例接受联合治疗,1424例接受单纯EVT。

主要发现

  • 联合治疗与单纯EVT在症状性颅内出血率上无差异(OR 0.61,95%CI 0.20-1.85;p=0.78)。
  • 两组死亡率无差异(OR 0.77,95%CI 0.54-1.10;p=0.15)。
  • 两组成功再灌注率无差异(OR 1.05,95%CI 0.52-2.15;p=0.89)。
  • 联合治疗组功能独立率较高但未达统计学显著性(OR 1.34,95%CI 1.00-1.80;p=0.053)。

关键数值与推荐

  • 成功再灌注定义为脑梗死溶栓评分2b-3级。
  • 功能独立定义为3个月时改良Rankin量表评分0-2分。
  • 辅助IAT药物为动脉内阿替普酶或尿激酶。

临床怎么用

  • 神经介入医师在特定情况下可考虑小剂量动脉内阿替普酶或尿激酶作为EVT的补救治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety and efficacy of intra-arterial thrombolysis (IAT) as an adjunct to endovascular thrombectomy (EVT) in ischemic stroke, we performed a systematic review and meta-analysis of the literature. METHODS: Searches were performed using MEDLINE, Embase, and Cochrane databases for studies that compared EVT with EVT with adjunctive IAT (EVT + IAT). Safety outcomes included symptomatic intracerebral hemorrhage and mortality at 3 months. Efficacy outcomes included successful reperfusion (Thrombolysis in Cerebral Infarction score of 2b-3) and functional independence, defined as a modified Rankin Scale score of 0-2 at 3 months. RESULTS: Five studies were identified that compared combined EVT + IAT (IA alteplase or urokinase) with EVT only and were included in the random-effects meta-analysis. There were 1693 EVT patients, including 269 patients treated with combined EVT + IAT and 1,424 patients receiving EVT only. Pooled analysis did not demonstrate any differences between EVT + IAT and EVT only in rates of symptomatic intracerebral hemorrhage (odds ratio [OR]: 0.61, 95% confidence interval [CI]: 0.20-1.85; p = 0.78), mortality (OR: 0.77, 95% CI: 0.54-1.10; p = 0.15), or successful reperfusion (OR: 1.05, 95% CI: 0.52-2.15; p = 0.89). There was a higher rate of functional independence in patients treated with EVT + IAT, although this was not statistically significant (OR: 1.34, 95% CI: 1.00-1.80; p = 0.053). CONCLUSION: Adjunctive IAT appears to be safe. In specific situations, neurointerventionists may be justified in administering small doses of intra-arterial alteplase or urokinase as rescue therapy during EVT.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Diprose WK, Wang MTM, Ghate K, et al. Adjunctive Intra-arterial Thrombolysis in Endovascular Thrombectomy: A Systematic Review and Meta-analysis. Neurology. 2021. PMID: 33931539. doi:10.1212/WNL.0000000000012112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。